Australian Prescriber is Australia's free, national, independent journal of drugs and therapeutics. It is published every two months online.
Our purpose is to help health professionals make informed choices when prescribing, including whether to prescribe a drug or not. To do this we provide independent, reliable and accessible information.
As well as publishing short didactic reviews, we facilitate debate about complex, controversial or uncertain therapeutic areas.
We are part of NPS MedicineWise, an independent, non-profit organisation providing medicines information and resources for health professionals, and stakeholders involved in the quality use of medicines. NPS MedicineWise is funded by the Australian Government Department of Health.
The information provided on the Australian Prescriber website is designed to support, not replace, the relationship that exists between someone and their health professional.
Readers can sign up for a publication e-alert, and can access the full text for free online.
The journal was first published by the Commonwealth Department of Health in 1975. It has since been published by the Therapeutic Goods Administration, then by the Pharmaceutical Benefits Branch of the Department of Health and Ageing, before finding a new home with the National Prescribing Service (now NPS MedicineWise) in 2002.
Australian Prescriber has been online since 1996. There are over 100 back issues available, including hundreds of editorials, articles, book reviews, comments on new drugs, case studies and much more. All issues from December 1999 onwards are available in both HTML text and PDF.
Until the end of 2009, the Adverse Drug Reactions Advisory Committee (ADRAC) Bulletin was distributed with Australian Prescriber. From February 2009 to February 2015, adverse drug reactions reporting was provided by the Therapeutic Goods Administration and published within Australian Prescriber as 'Medicines Safety Update'. 'Medicines Safety Update' is now exclusively published at www.tga.gov.au.
Australian Prescriber was a founding member of the International Society of Drug Bulletins and, in accordance with their policy, accepts no advertising. This allows the journal to comment freely and impartially on controversial issues.
Australian Prescriber is aimed at prescribing health professionals, as well as students of medicine, pharmacy and dentistry, and other interested individuals.
Health professionals from Australia and around the world may access Australian Prescriber online and receive an email alert to inform them when new material is published. Anyone can sign up for an email alert.
As Australian Prescriber is written primarily for health professionals, individuals should discuss any issues raised by material on this website with their doctor, pharmacist or other health professional.
Editorial Executive Committee
The role of the Editorial Executive Committee is to:
- select topics for publication in Australian Prescriber
- commission authors
- review draft articles and approve these for publication
- review comments on new drugs that have been prepared by the Editors
- select correspondence for publication
- oversee the general direction of the journal.
The Committee currently consists of the following members: the medical editor, the deputy editor, a psychiatrist, a geriatrician, a general physician, a general practitioner, a clinical pharmacologist and a pharmacist. It is supported by an editorial assistant, the production manager and coordinator, and administration.
The Committee liaises with NPS MedicineWise as an advisory group, with the Australian Prescriber Advisory Editorial Panel, with other independent Australian medicines information providers and a range of stakeholders engaged in the quality use of medicines in Australia and overseas.
Advisory Editorial Panel
The Advisory Editorial Panel supports the Editorial Executive Committee. Its members represent 49 major Australian specialist colleges and societies, providing a direct link with specialist practice. Panel members contribute suggestions for article topics and authors, and comments on draft articles.